Skip to content

PP&E (Net) at other companies

Baxter International logo
Baxter InternationalBAX
$2.91B+7.2%
PTH
Pelthos Therapeutics Inc.PTHS
$9.31M
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$4.94M-26.2%
RFL
Rafael Holdings, Inc.RFL
$1.52M-5.6%
Opko Health logo
Opko HealthOPK
$72.59M+2.0%
Organon logo
OrganonOGN
$1.28B+6.9%

Other financials

Income statement

See full
Revenue$9.1M-22.0%
Gross profit$7.2M-30.0%
Operating income-$3.1M-342%
Net income-$3.3M-362%
EPS (diluted)-$0.22-375%

Balance sheet

See full
Cash & equivalents$11.0M-27.1%
Total debt$4.8M-7.1%
Total equity$21.6M-24.5%
Total assets$71.0M+1.5%

Cash flow

See full
Operating cash flow$387.0K-90.1%
CapEx--100%
Free cash flow$387.0K-89.9%

Valuation

See full
Market cap$97.09M+138%
Enterprise value$90.91M+207%
P/S2.3×+1.3×

Profitability

See full
Gross margin82.9%-1.4pp
Operating margin-17.2%-125pp
Net margin-17.6%-103pp
FCF margin3.3%

Returns & leverage

See full
Return on equity-29.4%-86.3pp
Debt / equity0.2×0.0×
Current ratio-0.3×

Where this comes from

Reported directly by Cumberland Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cumberland Pharmaceuticals's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cumberland Pharmaceuticals's PP&E (net)?
Cumberland Pharmaceuticals (CPIX) reported PP&E (net) of $237.38K in Q1 2026.
How has Cumberland Pharmaceuticals's PP&E (net) changed year-over-year?
Cumberland Pharmaceuticals's PP&E (net) decreased by 20.5% year-over-year, from $298.74K to $237.38K.
What is the long-term trend for Cumberland Pharmaceuticals's PP&E (net)?
Over 5 years (2020 to 2025), Cumberland Pharmaceuticals's PP&E (net) has grown at a -14.3% compound annual growth rate (CAGR), from $574.17K to $264.72K.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.